🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study will be conducted in order to compare the bioavailability...
Status
Completed
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Start Date
2016-08
Trial ID
NCT02980458
Treatments Being Tested
1. To investigate the relative bioavailability (BA) of improved tablet form...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT02259868
Treatments Being Tested
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested
The primary objectives of this study are to compare the difference in glyco...
Status
Completed
Location
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
Start Date
2013-03
Trial ID
NCT01848990
The purpose of this study is to assess the efficacy and safety of Dexlansop...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00321984
Treatments Being Tested
The purpose of this Phase 1, prospective, uncontrolled, open-label, multice...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2014-09-30
Trial ID
NCT02216084
Treatments Being Tested
This study is in support of the annual application for the variation of the...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT00945438
Treatments Being Tested
This clinical study is a randomized, double-blind, double-dummy, parallel g...
Status
Suspended
Location
Sun City Clinical Research
Start Date
2022-12-14
Trial ID
NCT05324358
Treatments Being Tested
LCP-Tacro is an extended-release formulation of tacrolimus designed for onc...
Status
Completed
Location
Nephrology Department- Hospital Universitari Bellvtge
Start Date
2016-05
Trial ID
NCT02961608
Treatments Being Tested
This is a double-blinded, randomized, pharmacokinetic and safety study of 3...
Status
Completed
Location
Johns Hopkins University, Division of Clinical Pharmacology, Drug Development Unit
Start Date
2013-03
Trial ID
NCT01575418